Kronos Bio Inc

NASDAQ:KRON   3:59:43 PM EDT
33.84
-4.39 (-11.48%)
Earnings Announcements

Kronos Bio Reports Q3 Loss Per Share $6.48

Published: 11/18/2020 13:19 GMT
(KRON) - Kronos Bio Reports Recent Business Progress and Third Quarter 2020 Financial Results.
Q3 Loss per Share $6.48.
Q3 Earnings per Share Estimate $-1.47 -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.79

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.57

More details on our Analysts Page.